Table 2 Outcome indicators of the study population on the day of admission (nā=ā86)
From: Reducing the incidence of stroke-associated pneumonia: an evidence-based practice
Variables | Preimplementation group (nā=ā43) | Postimplementation group (nā=ā43) | F/U /Ļ2 | P |
|---|---|---|---|---|
Aspiration | 0 (0.0) | 0 (0.0) | Ā | / |
White blood cells (109/L) | 7.43 (5.89, 8.93) | 7.30 (5.60, 8.30) | 784.5 | 0.226 |
Procalcitonin (ng/ml) | 0.045 (0.033, 0.056) | 0.048 (0.036, 0.072) | 737.5 | 0.106 |
Hypersensitive C-reactive protein (mg/L) | 5.20 (4.02, 6.92) | 5.10 (3.24, 6.81) | 819.0 | 0.362 |
Hemoglobin (g/L) | 116 (108, 136) | 120 (109, 133) | 865.0 | 0.607 |
Serum albumin (g/L) | 36.93āĀ±ā3.29 | 38.24āĀ±ā3.31 | ā1.838 | 0.070 |